$2.76
-$0.32
(-10.39%)
Quote as of 4:00 PM EST on 02/10/12
Corcept Therapeutics, Inc.
NASDAQ:CORT
|
$2.76
-$0.32
(-10.39%)
|
|
| Today's Open | $3.05 |
|---|---|
| Previous Close | $3.08 |
| Daily Range | $2.50 - $3.05 |
| 52-Week Range | $2.50 - $5.07 |
| Market Cap | $232.48M |
| P/E Ratio | -8.32 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,538,802 |
| Average Daily Volume | 350,338 |
| Current FY EPS | -$0.36 |
CORT Information
| Description |
|---|
| A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Amgen, Vivus, Chelsea Therapeutics Prep for Key Catalysts in February
Regeneron Wins FDA Approval for Eye Drug: 3 Companies Up For Approval
Insider Picks: 5 Biotech Stocks Being Snapped Up By Insider Executives
5 Stocks Under $5 With Conservative Accounting Practices
22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12
9 Stocks Under $5 Dragged Down by Institutional Selling
20 Short Seller Targets Under $5
Neoprobe Looks to Become a Major Player in Oncology
Corcept Still Down but Positive Phase III Results Herald Potential Gains in 2011
